NAUTILUS NEWS

Nautilus Launches New Femme-Fatale Beer: "SIESTA" - A New Brew Designed to Help Female Drinkers Combat the Symptoms of PMS

 

BEVERLY HILLS, Calif.--(BEVERAGE MARKETING)--May 5, 2021--Richard H. Davis, Inventor and Chief Executive Officer of Nautilus International, Inc., announced today on this Cinco de Mayo national holiday the official U.S. launch of a new patent pending brew for PMS Relief called SIESTA™™ BEER, the world's first non-narcotic sleep inducing beer, containing a shot of natural L-theanine from Taiyo Kagaku Co., Ltd., a leading manufacturer of the amino acid L-theanine. SIESTA BEER is brewed in Mexico and contains 333 milligrams of naturally derived L-theanine amino acids >98% pure, 63 calories and 4.5 carbohydrates, with 6.3% alcohol by volume per 12 ounce clear long neck bottle. 

 

It is scientifically proven that three out of four women suffer from PMS, and the cause is mainly from a mix of swinging hormones, and fluctuating serotonin levels in the brain which could alter your mood and emotional stability. According to Davis, the genius behind the nutraceutical brew, who formulated SIESTA BEER with L-theanine because it has been proven to increase serotonin levels in the brain. “Human clinical trials have shown that L-theanine can promote an alert state of relaxation without drowsiness while diminishing normal symptoms of PMS,” explained Davis. "We are targeting female beer drinkers, looking for a Science-Based remedy for PMS Relief in an enjoyable beverage.” said Davis.

 

About Nautilus International, Inc.

 

Nautilus International, Inc., is a beverage marketing firm located in Beverly Hills, California, with the intent of accelerating the growth of the Company’s flagship product SIESTA beer. Nautilus is engaged in the private label bottled water industry. Their product brands are both licensed and developed in-house, for private label store brands or co-brands which are bottled at strategic locations throughout the United States, Canada and Europe. 

 

† These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. 

 

CONTACT:

 

Nautilus International, Inc.

Richard H. Davis, Inventor & CEO

(619) 728-5353 or (415) 779-4367

 

Email: nicofixcoffee@gmail.com

https://twitter.com/Suntheanine

https://nicofixcoffee.wixsite.com/siestabeer

 

Copyright Beverage Marketing 2021.